Home » Topics » Disease categories and therapies » Immune

Immune
RSS

HBV DNA vaccine elicits protective immune response in humans for first time

Dec. 10, 1998

News from ASH: lisofylline in BMT

Dec. 10, 1998

Avant receives further payment from Novartis for TP-10 development

Dec. 9, 1998

Patent covering cytokine trap technology issued to Regeneron

Dec. 7, 1998

StressGen's protein fusion vaccines elicit potent immune response without additional adjuvants

Dec. 7, 1998

Astra patents new pyrazolopyrimidinedione immunosuppressants

Dec. 4, 1998

MedImmune and Pasteur Merieux Connaught develop second-generation Lyme disease vaccine

Dec. 3, 1998

CPMP issues positive opinion for E.U. approval of Zenapax

Dec. 2, 1998

U.S. patent issued for Maxim's MaxVax technology

Dec. 2, 1998

Abbott purchases additional La Jolla stock

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...